Meyahealth
HomeGeneticsGenePPM1D gene
Back to Gene
PPM1D gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

PPM1D gene

The PPM1D gene provides instructions for creating an enzyme essential for cell division, immune development, and DNA repair.

Normal Function

The PPM1D gene provides instructions for making an enzyme called protein phosphatase 1D. This enzyme plays an essential role in cell division, immune cell development, gene expression, and the process by which cells create energy from food (metabolism). This enzyme is present in many of the body's tissues, including the developing brain.

Protein phosphatase 1D belongs to a group of enzymes known as the PP2C phosphatases, which help regulate cell development in response to environmental stress. The PP2C phosphatases turn on (activate) after attaching (binding) to charged molecules (ions) of manganese or magnesium. The activated enzyme can then regulate the activity of other proteins by removing a cluster of oxygen and phosphorous atoms (phosphate group) from that protein. This regulation helps repair DNA damage and return the cell to its normal state.

Protein phosphatase 1D specifically regulates tumor suppressors, such as tumor protein p53. Tumor suppressors are proteins that keep cells from growing and dividing too fast or in an uncontrolled way. By stopping cells with damaged DNA from dividing, tumor suppressors help prevent the development of tumors. Protein phosphatase 1D turns off proteins such as tumor protein p53 when they are no longer needed, which allows cells to continue growing and dividing.

Protein phosphatase 1D is also thought to play a role in regulating areas of tightly packed DNA called heterochromatin. Because gene expression is lower when DNA is tightly packed than when DNA is loosely packed, protein phosphatase 1D helps to turn off (silence) regions of DNA that are not needed.

Health Conditions Related to Genetic Changes

Jansen-de Vries syndrome

Certain variants (sometimes called mutations) in the PPM1D gene can cause Jansen-de Vries syndrome, a developmental disorder that affects many parts of the body. The variants that cause Jansen-de Vries syndrome occur in particular segments of the PPM1D gene known as exon 5 or exon 6. These variants disrupt the gene's instructions, resulting in an enzyme that does not function as it should. Research suggests that this enzyme is not able to reach the cell's nucleus. Without enough functional enzyme, heterochromatin regulation is disrupted, which likely alters gene expression. Altered gene expression may affect the early development of the brain.

Other Disorders

Variants in the PPM1D gene have been found in the tissues of people with various cancers, including breast cancer. These gene variants are known as somatic variants and are acquired during a person's lifetime. The variants are not inherited and are present only in certain cells. Variants in the PPM1D gene that are associated with cancer increase the activity of protein phosphatase 1D, which decreases the activity of tumor protein p53 and allows cancer cells to grow and divide.

Other Names for This Gene

  • PP2C-DELTA
  • protein phosphatase 1D, magnesium-dependent, delta isoform
  • protein phosphatase 2C, delta isoform
  • wild-type p53-induced phosphatase 1
  • WIP1

Genomic Location

The PPM1D gene is found on chromosome 17.

Frequently Asked Questions

Protein phosphatase 1D plays a significant role in the development and maturation of immune cells, particularly T-cells and B-cells. It helps regulate the signaling pathways that determine whether these immune cells survive, proliferate, or undergo programmed cell death. While the most prominent clinical manifestation of PPM1D mutations is cancer predisposition, the enzyme's involvement in immune regulation suggests that it may also influence how the body responds to infections and maintains immune homeostasis, although this aspect is less commonly discussed in standard patient care compared to cancer risk.
Mutations in the PPM1D gene are most commonly linked to Li-Fraumeni syndrome, a rare cancer predisposition syndrome. Individuals with this condition have a significantly increased risk of developing multiple types of cancer at a young age, including soft tissue sarcomas, breast cancer, brain tumors, and adrenocortical carcinomas. The mutation typically affects one copy of the gene, leading to a loss of function in the protein phosphatase 1D enzyme, which impairs the cell's ability to repair DNA damage and regulate the p53 tumor suppressor pathway.
The PPM1D gene encodes an enzyme that acts as a critical regulator of the cellular stress response. When DNA is damaged, the p53 protein is activated to halt cell division and initiate repair. The protein phosphatase 1D enzyme produced by PPM1D is responsible for turning off p53 once the damage is repaired, allowing the cell to resume normal growth. If this gene is mutated, the off-switch fails, leading to persistent p53 activity or, paradoxically, genomic instability because the cell cannot properly reset its stress response mechanisms, which contributes to tumor development.
Yes, PPM1D-related cancer predisposition can be identified through genetic testing that looks for specific point mutations in the gene. Because Li-Fraumeni syndrome is inherited in an autosomal dominant pattern, a parent with the mutation has a 50 percent chance of passing it to each child. If a mutation is found in a patient, first-degree relatives should be offered genetic counseling and testing. Early detection allows for enhanced surveillance protocols, such as regular MRI scans and blood tests, which can detect cancers at earlier, more treatable stages.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ